PT  - JOURNAL ARTICLE
AU  - Parry, Nicola
ED  - De Ferrari, Gaetano M.
TI  - Favorable Phase 2 Data for Ranolazine in AF
DP  - 2014 Aug 01
TA  - MD Conference Express
PG  - 24--25
VI  - 14
IP  - 9
4099  - http://mdc.sagepub.com/content/14/9/24.short
4100  - http://mdc.sagepub.com/content/14/9/24.full
AB  - This article presents results of the Ranolazine in Atrial Fibrillation Following an Electrical Cardioversion randomized trial [RAFFAELLO; NCT01534962], an international, double-blind, parallel, Phase 2, dose-ranging study testing three oral ranolazine doses. The results demonstrated safety and provided favorable findings with regard to efficacy for patients with atrial fibrillation.